Minimed Group, INC Form 4 insider transactions

MiniMed outlines its strategy for accelerated growth and market leadership in automated insulin delivery following its separation from Medtronic, highlighting product innovation and strong financial performance.

Mini-Med has filed a 425 document detailing a strategic split-off transaction aimed at separating its diabetes business into a new, independent entity.

Medtronic plc has initiated an exchange offer to spin off its remaining equity interest in MiniMed, filing a Form S-4 registration statement with the SEC.

MiniMed announces the launch of an exchange offer, marking the final step in its separation from Medtronic and transition to a fully independent public company.

MiniMed announces the final major step in its separation from Medtronic, launching an exchange offer for its remaining equity interest to operate as a fully independent company.

Medtronic plc announced an exchange offer allowing shareholders to swap Medtronic shares for MiniMed common stock as part of its separation strategy.

Medtronic plc has commenced an exchange offer for its shareholders to swap Medtronic ordinary shares for newly issued shares of MiniMed Group, Inc. as part of a divestment plan.

MiniMed has filed a Form S-4 Registration Statement for Medtronic's offer to exchange up to 225,361,295 MiniMed shares for outstanding Medtronic ordinary shares, marking a key step towards MiniMed's full separation.

Courtney Nelson Wills, SVP, Gen. Counsel, Corp. Sec. of MiniMed Group, Inc., reported a transaction in 1,762 shares of common stock on July 31, 2026.

Ali Dianaty, EVP Ch. Prod. & Tech Officer of MiniMed Group, Inc., reported a transaction in 8,012 shares of common stock on July 31, 2026.

Que Dallara, Chief Executive Officer and a Director of MiniMed Group, Inc., reported a transaction in 31,350 shares of common stock on July 31, 2026.

Chad Spooner, EVP, Chief Financial Officer of MiniMed Group, Inc., reported a transaction in 23,301 shares of common stock on July 28, 2026.

Gillian Chandrasena, SVP, Chief HR Officer of MiniMed Group, Inc., reported a transaction in 2,099 shares of common stock on July 28, 2026.

Courtney Nelson Wills of MiniMed Group, Inc. was granted restricted stock units and acquired additional shares, increasing beneficial ownership.

MiniMed Group, Inc. reports a grant of restricted stock units to VP, Chief Accounting Officer John Gyurci, alongside employee stock purchase plan acquisitions.

Gillian Chandrasena, SVP and Chief HR Officer of MiniMed Group, Inc., was granted restricted stock units (RSUs) on July 1, 2026, as part of the company's Long Term Incentive Plan.

MiniMed Group, Inc. reports the grant of restricted stock units to EVP, Chief Financial Officer Chad Spooner, with vesting schedules tied to anniversaries of the grant date.

MiniMed Group, Inc. reports the grant of restricted stock units to executive Ali Dianaty, with vesting over three years.

MiniMed Group, Inc. CEO Que Dallara has acquired a substantial number of restricted stock units (RSUs) as part of the company's long-term incentive plan.

MiniMed Group, Inc. CEO Que Dallara disposed of 4,809 common shares to cover tax obligations related to RSU vesting.

MiniMed Group, Inc. officer John Gyurci acquired 15,322 restricted stock units following the company's separation from Medtronic plc.

MiniMed Group, Inc.'s SVP, Chief Human Resources Officer, Gillian Chandrasena, was granted 129,765 restricted stock units following the company's separation from Medtronic plc.

MiniMed Group's General Counsel, Courtney Nelson Wills, converted over 55,000 Medtronic equity awards into MiniMed restricted stock units following the company's separation from Medtronic plc.

MiniMed Group's EVP, Chief Product & Technology Officer, Ali Dianaty, acquired 191,258 restricted stock units following the company's separation from Medtronic.

MiniMed Group's EVP and CFO, Chad Spooner, converted his Medtronic equity awards into 269,401 MiniMed restricted stock units following the company's separation from Medtronic plc.

MiniMed Group, Inc. CEO Que Dallara acquired 621,563 restricted stock units following the company's separation from Medtronic plc.